TRIM24 and ovarian serous cystadenocarcinoma: As shown in Fig. 1a and 1b, compared to normal ovary tissues, TRIM24 mRNA expression had a significant enhancement in ovarian serous cystadenocarcinoma (TCGA Ovarian database: P = 8.71E-6, t = 9.27, and TCGA Ovarian 2 database: P = 4.39E-70, t = 20.198).